$SNEX

Lyon Charles M sold $1.2M of SNEX

Lyon Charles M (President) sold 9,000 shares of StoneX Group Inc. (SNEX) at $131.96 ($1.19M total) on 2026-06-12.

Original reporting
SEC EDGAR · Lyon Charles M
Published Jun 16, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNEX
Neutral
medium confidence
Mentioned
$SNEX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNEXNeutralLow
01

Why it matters

The disclosure updates the insider ownership record and may marginally influence sentiment, but it does not provide new operational, financial, or regulatory information.

02

Market read

Traders may monitor SNEX for continued insider selling or other catalysts, but the filing alone is unlikely to drive a major repricing.

03

What to watch

The article provides only the sale details; it does not state whether there were offsetting buys, option exercises, or broader insider activity around the same period.

Relevance 6/10Novelty 6/10Timing: Form 4 filed 2026-06-16 (sale dated 2026-06-12)

Background

This is an SEC Form 4 insider transaction disclosure for StoneX Group Inc. (SNEX).

Company-level read

Ticker impact

$SNEXNeutralMedium confidence
Context

StoneX Group insider Lyon Charles M (President) sold 9,000 shares in an open-market transaction at $131.96 on 2026-06-12.

Expected impact

Likely limited/short-lived impact; watch for follow-on selling or concurrent news.

Evidence & confidence

The filing is primary-source and company-specific, but it is an open-market sale with no 10b5-1 plan disclosed and no accompanying fundamental catalyst in the text.

Market effects

No sector-level read-across; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs; without a 10b5-1 plan, the signal is ambiguous rather than bearish.

Key entities

  • StoneX Group Inc.

    Subject of the Form 4 insider sale disclosure.

  • Lyon Charles M

    President who sold 9,000 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WGOMedAI 8/10

Winnebago stock rises as StoneX lowers price target on industry outlook

StoneX lowered its price target on Winnebago (WGO) to $36 from $40, maintaining a Buy rating. The stock trades at $26.83 with a 5.62% dividend yield. Winnebago issued fiscal 2027 guidance for sales of $2.65B-$2.80B and adjusted EPS of $1.65-$2.25, with midpoints above consensus. The company reduced 2026 RV shipment expectations and guided 2027 shipments to 265,000-295,000 units. The stock rose 10.5% on Monday following earnings and guidance.

$MXLMed

MaxLinear stock rating reiterated at Buy by StoneX ahead of results

StoneX reiterated a Buy rating on MaxLinear (MXL) with a $125 price target ahead of its October 22 earnings report. The firm expects Q3 revenue of $215M-$220M, matching consensus. MXL shares are down 20% in a week but up 320% year-to-date. S&P upgraded its outlook to positive, citing strong infrastructure revenue growth. Analysts highlight MXL's potential in the optical market.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.